Search results
5 days ago · TORONTO, May 30, 2024 /CNW/ - Today, Sanofi, a global healthcare company, announced the opening of a new state-of-the-art pediatric and adult vaccine manufacturing facility at its Toronto Campus ...
4 days ago · About Sanofi and Regeneron’s COPD Clinical Research Program Sanofi and Regeneron are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation play in the disease progression through the investigation of two potentially first-in-class biologics, Dupixent and itepekimab.
4 days ago · Sanofi and partner Regeneron Pharmaceuticals have secured the European regulator's backing for use of Dupixent in patients with a chronic lung disease even as the U.S. Food and Drug Administration ...
4 days ago · Sanofi stock chart. Ticker table to check the latest price updates. Date & Time: 31 May 2024 17:37 (GMT+02:00) Share. Market. Last. High.
4 days ago · About Sanofi and Regeneron’s COPD Clinical Research Program Sanofi and Regeneron are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation play in the disease progression through the investigation of two potentially first-in-class biologics, Dupixent and itepekimab.
2 days ago · Sanofi will press ahead with plans for a spin-off of its consumer division, which could be one of Europe’s biggest deals this year, adding bankers to work on a sale process and preparations for ...
4 days ago · Paris, May 31, 2024. Sanofi’s global employee shareholder plan, Action 2024, opens on June 4, 2024, to around 80,000 employees in 56 countries. Now in its 10 th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to secure that employees benefit from the company growth and success.
